JA
JW Asset Management, LLC
13F filer · CIK 0001549738Reported Aug 7, 2026
Net seller this quarter
13F portfolio value$320MU.S. long equity reported on 13F
Positions205 new · 3 closed
Net flow last quarter-$39.6MBuys minus sells
Top 10 positions weight95.6%Concentration
Holdings
13F · last 4 quarters freeScroll for earlier quarters
| Company | Value | % of portfolio | % of company | POSITION CHANGE qoq % | First reported |
|---|---|---|---|---|---|
| Q2 2026Reported Aug 7, 202620 positions | |||||
| $231M | 72.24% | 9.04% | -12.1% | Q3 2018 | |
| $17.8M | 5.55% | 0.01% | +20.2% | Q1 2026 | |
| $14.5M | 4.52% | 0.38% | Not reported | Q3 2023 | |
| CPCPRXCatalyst Pharmaceuticals, Inc. | $12.2M | 3.82% | 0.32% | Not reported | Q4 2022 |
| $8.08M | 2.53% | 0.00% | Not reported | Q4 2016 | |
| $6.61M | 2.07% | 0.04% | -12.2% | Q4 2025 | |
| $4.62M | 1.45% | 0.89% | -1.4% | Q1 2022 | |
| $4.01M | 1.25% | Not reported | Not reported | Q2 2025 | |
| $3.92M | 1.23% | 0.04% | Not reported | Q1 2025 | |
| $3.05M | 0.95% | 0.00% | Not reported | Q4 2016 | |
| $2.58M | 0.81% | 0.02% | -12.1% | Q4 2025 | |
| $1.8M | 0.56% | 0.02% | Not reported | Q3 2024 | |
| $1.7M | 0.53% | 0.03% | New | Q2 2026 | |
| $1.6M | 0.50% | 1.98% | Not reported | Q4 2014 | |
| $1.51M | 0.47% | 0.00% | New | Q2 2026 | |
| $1.26M | 0.40% | 0.02% | Not reported | Q4 2014 | |
| $953K | 0.30% | 0.00% | New | Q2 2026 | |
| $824K | 0.26% | 0.04% | New | Q2 2026 | |
| $811K | 0.25% | 0.01% | -37.1% | Q3 2025 | |
| $220K | 0.07% | 0.11% | -5.4% | Q3 2023 | |
| Q1 2026Reported May 8, 202618 positions | |||||
| $174M | 71.39% | 10.42% | Not reported | Q3 2018 | |
| $10.5M | 4.30% | 0.38% | Not reported | Q3 2023 | |
| CPCPRXCatalyst Pharmaceuticals, Inc. | $9.62M | 3.95% | 0.32% | Not reported | Q4 2022 |
| $7.9M | 3.24% | Not reported | Not reported | Q1 2016 | |
| $5.64M | 2.32% | 0.05% | Not reported | Q4 2025 | |
| $4.98M | 2.04% | Not reported | Not reported | Q1 2015 | |
| $4.6M | 1.89% | 0.91% | Not reported | Q1 2022 | |
| $4.13M | 1.70% | 0.00% | New | Q1 2026 | |
| $4.05M | 1.66% | 0.04% | Not reported | Q1 2025 | |
| $3.44M | 1.41% | Not reported | Not reported | Q2 2025 | |
| $3M | 1.23% | 1.99% | +2.2% | Q4 2014 | |
| $2.82M | 1.16% | 0.03% | -39.0% | Q4 2025 | |
| $2.66M | 1.09% | 0.00% | Not reported | Q4 2016 | |
| $2.36M | 0.97% | 0.00% | Not reported | Q4 2016 | |
| $2.28M | 0.94% | 0.02% | +42.9% | Q3 2024 | |
| $610K | 0.25% | 0.02% | -83.8% | Q3 2025 | |
| $577K | 0.24% | Not reported | Not reported | Q4 2025 | |
| $234K | 0.10% | 0.12% | Not reported | Q3 2023 | |
| Q4 2025Reported Feb 6, 202617 positions | |||||
| $223M | 72.63% | 10.45% | -0.7% | Q3 2018 | |
| $11.6M | 3.77% | 0.38% | Not reported | Q3 2023 | |
| $10.9M | 3.53% | 0.04% | Not reported | Q4 2024 | |
| CPCPRXCatalyst Pharmaceuticals, Inc. | $9.07M | 2.95% | 0.32% | Not reported | Q4 2022 |
| $8.64M | 2.81% | Not reported | Not reported | Q1 2016 | |
| $6.32M | 2.06% | 0.05% | New | Q4 2025 | |
| $6.22M | 2.02% | 0.06% | New | Q4 2025 | |
| $5.77M | 1.88% | 0.91% | -8.6% | Q1 2022 | |
| $5.74M | 1.87% | Not reported | -58.5% | Q1 2015 | |
| $4.77M | 1.55% | 1.95% | +11.5% | Q4 2014 | |
| $3.54M | 1.15% | Not reported | Not reported | Q2 2025 | |
| $3.44M | 1.12% | 0.11% | -9.3% | Q3 2025 | |
| $2.93M | 0.96% | 0.04% | Not reported | Q1 2025 | |
| $2.84M | 0.93% | 0.00% | Not reported | Q4 2016 | |
| $1.32M | 0.43% | 0.01% | +40.0% | Q3 2024 | |
| $614K | 0.20% | Not reported | New | Q4 2025 | |
| $271K | 0.09% | 0.12% | Not reported | Q3 2023 | |
| Q3 2025Reported Nov 7, 202517 positions | |||||
| $126M | 60.64% | 10.61% | -0.3% | Q3 2018 | |
| $15.4M | 7.38% | Not reported | +52.9% | Q1 2015 | |
| $13.7M | 6.60% | 0.04% | -7.7% | Q4 2024 | |
| $11.8M | 5.65% | 0.01% | Not reported | Q2 2025 | |
| $9.28M | 4.46% | 0.38% | -5.2% | Q3 2023 | |
| CPCPRXCatalyst Pharmaceuticals, Inc. | $7.65M | 3.67% | 0.32% | Not reported | Q4 2022 |
| $5.29M | 2.54% | 1.04% | -3.1% | Q1 2022 | |
| $4.15M | 1.99% | 2.15% | +40.9% | Q4 2014 | |
| $3.14M | 1.50% | Not reported | +400.0% | Q2 2025 | |
| $3.02M | 1.45% | 0.04% | Not reported | Q1 2025 | |
| $2.85M | 1.37% | 0.00% | +24.5% | Q4 2016 | |
| $2.5M | 1.20% | 0.13% | New | Q3 2025 | |
| $1.72M | 0.82% | 0.04% | Not reported | Q4 2023 | |
| $774K | 0.37% | 0.01% | Not reported | Q3 2024 | |
| $371K | 0.18% | 0.13% | Not reported | Q3 2023 | |
| $214K | 0.10% | 0.00% | Not reported | Q4 2024 | |
| $157K | 0.08% | 0.04% | New | Q3 2025 | |
Premium opens every quarter this fund has filed